Dravya Discovery offers consultancy and CRO Services in Ophthalmology, Oncology and Neuroscience

Dravya Discovery Services


"The lab had no in-house capabilities for angiogenic or ophthalmic assays; therefore all work was outsourced. Very few CROs were offering good data, quality based assays, even fewer offered consultancy services."

 - Dr. Vineeta Tripathi, CEO, CSO Dravya Discovery

Dravya Discovery was founded as the team identified an unmet market need in the area of ophthalmic preclinical research and target validation.

Our niche CRO offers expertise in cell, tissue and animal-based drug discovery and development assay.


Our disease-relevant, fit-for-purpose, clinically validated translational assays and target-to-assay consultancy help scientists in drug development and target validation who need quality data for lead selection.

Our high and medium throughput assays screen drug candidates in campaign sizes from 1 to >100 molecules.

Dravya's Mantra

GLP-consistent execution

IP consciousness

Effective communication

Passion for science 

Dravya's experience.

Your scientific needs.

A Promising partnership.

Our analytic expertise and GLP compliant execution deliver pre-IND quality data. With in-house study design services, digital data analyses, and our teams’ vast experience in big pharma we are the right CRO to support your goal: Get your drug developed, fast.

How can we help you?

Indications we support


wet / dry





Retinopathy of Prematurity

Get in touch with us today

Simply drop us a note below